𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A randomized trial of 24 versus 48 weeks of peginterferon α-2a in patients infected with chronic hepatitis C virus genotype 2 or low viral load genotype 1: a multicenter national study in Japan

✍ Scribed by Yoshiaki Iwasaki; Yasushi Shiratori; Shuhei Hige; Shuhei Nishiguchi; Hitoshi Takagi; Morikazu Onji; Haruhiko Yoshida; Namiki Izumi; Yutaka Kohgo; Kyosuke Yamamoto; Nobuhiro Sato; Akitaka Shibuya; Hidetsugu Saito; Michio Sata; Kazuyuki Suzuki; Shuichi Kaneko; Mitsuhiko Moriyama; Masao Omata

Book ID
107593829
Publisher
Springer-Verlag
Year
2009
Tongue
English
Weight
343 KB
Volume
3
Category
Article
ISSN
1936-0533

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized comparison of 12 or 24 weeks
Randomized comparison of 12 or 24 weeks of peginterferon α-2a and ribavirin in chronic hepatitis C virus genotype 2/3 infection
✍ Martin Lagging; Nina Langeland; Court Pedersen; Martti Färkkilä; Mads Rauning Bu 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 377 KB

Previous trials investigating the efficacy of treatment durations shorter than the standard of 24 weeks for chronic hepatitis C virus (HCV) genotype 2/3 infections have yielded discordant results. The aims of this investigator-initiated phase III study were to compare the efficacy of 12 or 24 weeks